Literature DB >> 3836014

Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury.

A R Blight.   

Abstract

Recent studies of the chronic morphology and physiology of experimental spinal cord injury (SCI) in the cat are reviewed and their conclusions outlined. In particular, variations in chronic dysmyelination of the lesion have been found to be largely independent of injury intensity, suggesting a secondary pathologic origin. New morphometric studies of the subacute development of contusion lesions are described. Using electron microscopy and light microscopic line-sampling of myelinated axons, it was found that demyelination of axons that survived the initial injury occurred largely between 2 and 7 days after contusion and did not accompany the much more rapid dissolution of myelin from those axons that degenerated within the first 2 days. The number of apparently intact axons at the center of the lesion declined by a factor of 2 or more in the same interval of 2-7 days. This secondary pathology was coincident with dense invasion of the lesion by macrophages and their phagocytosis of the membraneous debris remaining from the initial hemorrhagic necrosis. It is concluded that posttraumatic inflammation in the spinal cord should be investigated in more detail as a possible contributor to chronic deficits. In addition, these data emphasize the importance of defining the nature, time of occurrence, and proportional significance of secondary damage in order to evaluate those studies and hypotheses that attempt to differentiate acute secondary pathophysiology from primary degenerative processes.

Entities:  

Mesh:

Year:  1985        PMID: 3836014     DOI: 10.1089/cns.1985.2.299

Source DB:  PubMed          Journal:  Cent Nerv Syst Trauma        ISSN: 0737-5999


  69 in total

1.  Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord.

Authors:  D M McTigue; P Wei; B T Stokes
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

2.  NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo.

Authors:  Anna P Mashkina; Dasha Cizkova; Ivo Vanicky; Alexander A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

Review 3.  Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.

Authors:  R Shi; J C Page; M Tully
Journal:  Free Radic Res       Date:  2015-04-16

4.  Neuronal and glial apoptosis after traumatic spinal cord injury.

Authors:  X Z Liu; X M Xu; R Hu; C Du; S X Zhang; J W McDonald; H X Dong; Y J Wu; G S Fan; M F Jacquin; C Y Hsu; D W Choi
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

5.  Pathology dynamics predict spinal cord injury therapeutic success.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

6.  Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.

Authors:  S Liu; Y Qu; T J Stewart; M J Howard; S Chakrabortty; T F Holekamp; J W McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 7.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 8.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

9.  B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice.

Authors:  Daniel P Ankeny; Zhen Guan; Phillip G Popovich
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

10.  In vivo longitudinal Myelin Water Imaging in rat spinal cord following dorsal column transection injury.

Authors:  Piotr Kozlowski; Paulina Rosicka; Jie Liu; Andrew C Yung; Wolfram Tetzlaff
Journal:  Magn Reson Imaging       Date:  2013-12-27       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.